Why is Evoq Remedies falling/rising?

As of 29-Sep, Evoq Remedies Ltd is experiencing a decline in its stock price, currently at 4.15, which reflects a decrease of 0.21 or 4.82%. The stock has underperformed its sector by 4.96% today and has been on a consecutive downward trend for the last two days, resulting in a total drop of 9.39% during this period. Over the past week, the stock has decreased by 2.81%, while its one-month performance shows a significant increase of 35.18%. However, year-to-date, the stock has fallen by 46.79%, indicating a longer-term struggle. Additionally, the delivery volume has decreased by 59.68% against the five-day average, suggesting a decline in investor participation, which may contribute to the stock's recent price movement.
In the broader market context, the Sensex has also faced challenges, with a decline of 2.18% over the past week. While Evoq Remedies has outperformed the benchmark in the one-month period, its year-to-date and one-year returns are significantly worse than the Sensex, which has gained 2.85% and lost only 6.08%, respectively. The stark contrast in performance over these time frames highlights the difficulties Evoq Remedies is facing compared to the overall market. The stock's liquidity remains adequate for trading, but the falling investor participation may indicate a lack of confidence, further exacerbating its price decline.